Summit Trail Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Buy |
+36,097
| New | +$2.82M | 0.05% | 197 |
|
|
2024
Q4 | – | Sell |
-13,916
| Closed | -$918K | – | 512 |
|
|
2024
Q3 | $918K | Buy |
13,916
+103
| +0.7% | +$6.8K | 0.02% | 280 |
|
|
2024
Q2 | $1.28M | Buy |
13,813
+102
| +0.7% | +$9.42K | 0.03% | 198 |
|
|
2024
Q1 | $1.31M | Buy |
13,711
+189
| +1% | +$18.1K | 0.03% | 176 |
|
|
2023
Q4 | $1.03M | Buy |
13,522
+192
| +1% | +$14.6K | 0.03% | 172 |
|
|
2023
Q3 | $924K | Buy |
+13,330
| New | +$924K | 0.03% | 177 |
|
|
2023
Q2 | – | Sell |
-3,560
| Closed | -$295K | – | 543 |
|
|
2023
Q1 | $295K | Buy |
3,560
+657
| +23% | +$54.4K | 0.01% | 324 |
|
|
2022
Q4 | $217K | Buy |
+2,903
| New | +$217K | 0.01% | 345 |
|
|
2022
Q3 | – | Sell |
-2,501
| Closed | -$238K | – | 387 |
|
|
2022
Q2 | $238K | Buy |
+2,501
| New | +$238K | 0.01% | 315 |
|
|
2022
Q1 | – | Sell |
-2,837
| Closed | -$368K | – | 342 |
|
|
2021
Q4 | $368K | Buy |
2,837
+311
| +12% | +$40.3K | 0.02% | 200 |
|
|
2021
Q3 | $286K | Buy |
2,526
+164
| +7% | +$18.6K | 0.02% | 204 |
|
|
2021
Q2 | $245K | Buy |
+2,362
| New | +$245K | 0.02% | 191 |
|
|
2020
Q4 | – | Sell |
-2,631
| Closed | -$211K | – | 214 |
|
|
2020
Q3 | $211K | Buy |
+2,631
| New | +$211K | 0.04% | 196 |
|
|
2018
Q1 | – | Sell |
-2,097
| Closed | -$86K | – | 820 |
|
|
2017
Q4 | $86K | Buy |
+2,097
| New | +$86K | 0.01% | 668 |
|